The Market In 5 Minutes: G7 Fallout, North Korea Summit, Match Group And More

IN THE NEWS

The upcoming week will keep biotech investors busy with a handful of conferences and clinical trail presentations from companies including Abbvie ABBV and Chimerix CMRX. Link

Before investors throw up their arms and give up on understanding why the market reacts the way it does, it’s important to understand the psychology behind market catalysts. Link

All eyes will be on Singapore Monday night as President Trump meets with North Korean Leader Kim Jung Un. Reuters is covering the event with live updates. Link

Russian President Vladimir Putin called for a meeting with President Trump over the weekend. He said, "we are ready for this. I believe that the ball is in America’s court.” Link

The Canadian dollar fell against all its major peers after U.S. President Donald Trump revoked his support for a joint Group-of-Seven statement and criticized his neighboring leader Justin Trudeau. Link $

Bankers are vying for the world’s hyper-wealthy as never before. And they are holding out investments that are tantalizingly off-limits to the rest of us. This is how the super-rich keep getting super-richer. Only a privileged few can bankroll multimillion-dollar ventures or buy entire companies. Link $

ECONOMIC DATA

The Treasury is set to auction 3-month bills, 6-month bills and 3-year notes at 11:30 a.m. ET.
The Treasury will auction 10-year notes at 1:00 p.m. ET.

ANALYST RATINGS

Jefferies upgrades Match Group MTCH to Buy and raises its price target from $40 to $50.
Raymond James upgrades Petrobras PBR to Market Perform.
Wells Fargo downgrades DTE Energy DTE to Market Perform.

This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Posted In: NewsGlobalTop StoriesPre-Market OutlookMarketsMarket in 5 minutes
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...